MSF Scientific Days 2018

24-25 May 2018
London, UK

The MSF Scientific Days share the knowledge of what works in humanitarian medical programming. The aim is to help improve the quality of care provided to patients and populations by sharing research conducted in field programmes.

 

Presentations

Prospective study of Lopinavir based ART for HIV Infected ChildreN Globally (LIVING study): Interim 48-week effectiveness and safety results
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa

Post-Kala-azar dermal leishmaniasis (PKDL), a common venture between DNDi and MSF towards the Elimination of Kala-azar in the Indian subcontinent
Leishmaniasis Team, DNDi

HIV-Visceral Leishmaniasis co-infection: DNDi/MSF common strategy for changing the drug policy in East Africa
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Geneva

 

 

More information: